These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Bioactivation of the cysteine-S-conjugate and mercapturic acid of tetrafluoroethylene to acylating reactive intermediates in the rat: dependence of activation and deactivation activities on acetyl coenzyme A availability.
    Author: Commandeur JN, De Kanter FJ, Vermeulen NP.
    Journal: Mol Pharmacol; 1989 Oct; 36(4):654-63. PubMed ID: 2811861.
    Abstract:
    The beta-lyase-dependent bioactivation of S-conjugates of tetrafluoroethylene by subcellular fractions from rat liver and rat kidney was studied. Incubation of both hepatic and renal cytosol with S-(1,2,2,2-tetrafluoroethyl)-l-cysteine (TFE-Cys) resulted in the formation of previously unidentified difluorothionamides, indicating difluorothionoacyl fluoride as the main reactive intermediate derived from the beta-lyase-dependent bioactivation of TFE-Cys. The presence of N-difluorothionoacetyl-S-(1,1,2,2-tetrafluoroethyl)-l-cystei ne (TFE-PMS) and difluoroacetic acid in urine of rats treated with N-acetyl-S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFE-NAC) points to a similar mechanism of bioactivation in vivo. When TFE-NAC was incubated with 11,000 X g supernatants of rat kidney and liver in the absence of exogenous acetyl coenzyme A (acetyl-CoA), N-deacetylation and subsequent beta-lyase-dependent activation to difluorothionoacyl fluoride could be observed. Both the N-deacetylation of TFE-NAC and the beta-lyase-dependent activation of TFE-Cys were much faster in rat kidney then in rat liver. When TFE-Cys was incubated with 11,000 X g supernatants of rat kidney and rat liver, formation of TFE-NAC could only be observed in the presence of 2 mM exogenous acetyl-CoA; the initial rate of N-acetylation was 5-fold higher in renal then in hepatic fractions. Under these conditions, formation of TFE-PMS was very low. The low urinary excretion of unchanged TFE-NAC (3-5% of dose) upon administration of TFE-NAC points to a high N-deacetylation/N-acetylation ratio in vivo. Due to a very high turn-over of TFE-NAC/TFE-Cys, the availability of the cofactor for N-acetylation, acetyl-CoA, might be rate limiting in the kidney, resulting in accumulation of TFE-Cys followed by increasing beta-lyase-dependent bioactivation of TFE-Cys to reactive intermediates.
    [Abstract] [Full Text] [Related] [New Search]